ABCC8 and pulmonary arterial hypertension: Heterozygous loss-of-function mutations in ABCC8 have also been reported in patients with PAH and it may promote decreased apoptosis and enhanced inflammation and hyperplasia, although the involved molecular mechanisms remain unclear [68,69].